| Literature DB >> 33530406 |
Piotr Schulz1,2, Szymon Hryhorowicz3, Anna Maria Rychter1, Agnieszka Zawada1, Ryszard Słomski3, Agnieszka Dobrowolska1, Iwona Krela-Kaźmierczak1.
Abstract
The endocannabinoid system (ECS) is an endogenous signaling system formed by specific receptors (cannabinoid type 1 and type 2 (CB1 and CB2)), their endogenous ligands (endocannabinoids), and enzymes involved in their synthesis and degradation. The ECS, centrally and peripherally, is involved in various physiological processes, including regulation of energy balance, promotion of metabolic process, food intake, weight gain, promotion of fat accumulation in adipocytes, and regulation of body homeostasis; thus, its overactivity may be related to obesity. In this review, we try to explain the role of the ECS and the impact of genetic factors on endocannabinoid system modulation in the pathogenesis of obesity, which is a global and civilizational problem affecting the entire world population regardless of age. We also emphasize that the search for potential new targets for health assessment, treatment, and the development of possible therapies in obesity is of great importance.Entities:
Keywords: cannabinoid receptors; endocannabinoid system; obesity; obesity genes; obesity pathogenesis
Mesh:
Substances:
Year: 2021 PMID: 33530406 PMCID: PMC7911032 DOI: 10.3390/nu13020373
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717